These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30983153)

  • 41. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
    Tian K; Su Y; Ding J; Wang D; Zhan Y; Li Y; Liang J; Lin X; Song F; Wang Z; Xu J; Liu Q; Zhao J
    Life Sci; 2020 Mar; 244():117336. PubMed ID: 31972206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.
    Dong Y; Song C; Wang Y; Lei Z; Xu F; Guan H; Chen A; Li F
    Cell Signal; 2017 Jun; 34():55-65. PubMed ID: 28302565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
    Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
    PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling.
    Ding N; Lu Y; Cui H; Ma Q; Qiu D; Wei X; Dou C; Cao N
    BMB Rep; 2020 Mar; 53(3):154-159. PubMed ID: 31964464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antioxidant PDA-PEG nanoparticles alleviate early osteoarthritis by inhibiting osteoclastogenesis and angiogenesis in subchondral bone.
    Wu Z; Yuan K; Zhang Q; Guo JJ; Yang H; Zhou F
    J Nanobiotechnology; 2022 Nov; 20(1):479. PubMed ID: 36384720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells.
    Jeong JW; Choi SH; Han MH; Kim GY; Park C; Hong SH; Lee BJ; Park EK; Kim SO; Leem SH; Jeon YJ; Choi YH
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
    Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
    J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quercetin alleviates rat osteoarthritis by inhibiting inflammation and apoptosis of chondrocytes, modulating synovial macrophages polarization to M2 macrophages.
    Hu Y; Gui Z; Zhou Y; Xia L; Lin K; Xu Y
    Free Radic Biol Med; 2019 Dec; 145():146-160. PubMed ID: 31550528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of BioAggregate on Receptor Activator of Nuclear Factor-Kappa B Ligand-induced Osteoclastogenesis from Murine Macrophage Cell Line In Vitro.
    Zhang J; Zhu L; Yan P; Peng B
    J Endod; 2015 Aug; 41(8):1265-71. PubMed ID: 25975181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
    Meng J; Zhou C; Zhang W; Wang W; He B; Hu B; Jiang G; Wang Y; Hong J; Li S; He J; Yan S; Yan W
    J Cell Mol Med; 2019 Oct; 23(10):6730-6743. PubMed ID: 31328430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion.
    Fang C; Guo JW; Wang YJ; Li XQ; Zhang H; Cui J; Hu Y; Jing YY; Chen X; Su JC
    Acta Pharmacol Sin; 2022 May; 43(5):1299-1310. PubMed ID: 34381182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species production.
    Song D; Cao Z; Liu Z; Tickner J; Qiu H; Wang C; Chen K; Wang Z; Dong S; Xu J
    J Cell Physiol; 2018 Dec; 233(12):9674-9684. PubMed ID: 29968926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function.
    Kim HJ; Yoon HJ; Kim BK; Kang WY; Seong SJ; Lim MS; Kim SY; Yoon YR
    J Cell Physiol; 2016 Apr; 231(4):844-51. PubMed ID: 26280807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells.
    Nikhil K; Sharan S; Roy P
    Pharmacol Rep; 2015 Dec; 67(6):1264-72. PubMed ID: 26481551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M; Suzuki R; Shirataki Y; Sakagami H; Tamura N; Tomomura A
    PLoS One; 2015; 10(6):e0130174. PubMed ID: 26083531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.